New prognostic model in patients with advanced urothelial carcinoma treated with second-line immune checkpoint inhibitors
Aristotelis Bamias*, Axel Merseburger, Yohann Loriot, Nicholas James, Ernest Choy, Daniel Castellano, F. Lopez-Rios, Fabio Calabrò, Mario Kramer, Guillermo De Velasco, Roubini Zakopoulou, Kimon Tzannis, Cora N. Sternberg
Untersuchen Sie die Forschungsthemen von „New prognostic model in patients with advanced urothelial carcinoma treated with second-line immune checkpoint inhibitors“. Zusammen bilden sie einen einzigartigen Fingerprint.